Contents

Current Drug Targets, Volume 12 - Number 3

Editorial [Hot Topic: Natural Products Triggering Biological Targets (Guest Editor: Francesco Epifano)]

, 12(3): 287

Francesco Epifano


DOI: 10.2174/138945011794815239




Natural Products Triggering Biological Targets- A Review of the Anti-Inflammatory Phytochemicals Targeting the Arachidonic Acid Pathway in Allergy Asthma and Rheumatoid Arthritis

, 12(3): 288 - 301

Sophie Chen


DOI: 10.2174/138945011794815347




Triterpene Derivatives as Inhibitors of Protein Involved in the Inflammatory Process: Molecules Interfering with Phospholipase A2, Cycloxygenase, and Lipoxygenase

, 12(3): 302 - 321

Alessandra Braca, Fabrizio Dal Piaz, Stefania Marzocco, Giuseppina Autore, Antonio Vassallo and Nunziatina De Tommasi


DOI: 10.2174/138945011794815284




Proteases of Porphyromonas gingivalis as Important Virulence Factors in Periodontal Disease and Potential Targets for Plant-Derived Compounds: A Review Article

, 12(3): 322 - 331

Daniel Grenier and Vu Dang La


DOI: 10.2174/138945011794815310




The Targets of Curcumin

, 12(3): 332 - 347

Hongyu Zhou, Christopher S. Beevers and Shile Huang


DOI: 10.2174/138945011794815356




Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs

, 12(3): 348 - 356

Gonzalo Sanchez-Duffhues, Minh Q. Vo, Moises Perez, Marco A. Calzado, Santiago Moreno, Giovanni Appendino and Eduardo Munoz


DOI: 10.2174/138945011794815266




Therapeutic and Diagnostic Applications of Nanoparticles

, 12(3): 357 - 365

Mahmoud Youns, Jorg D. Hoheisel and Thomas Efferth


DOI: 10.2174/138945011794815257




Anthraquinones: Analytical Techniques as a Novel Tool to Investigate on the Triggering of Biological Targets

, 12(3): 366 - 380

Marcello Locatelli


DOI: 10.2174/138945011794815338




Auraptene: A Natural Biologically Active Compound with Multiple Targets

, 12(3): 381 - 386

Salvatore Genovese and Francesco Epifano


DOI: 10.2174/138945011794815248




Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

, 12(3): 387 - 391

Hans Carl Hasselbalch


DOI: 10.2174/138945011794815220




Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives

, 12(3): 392 - 419

Hans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, Morten Krogh Jensen and Jean-Jacques Kiladjian


DOI: 10.2174/138945011794815275




Interferon alpha for Treatment of Chronic Myeloid Leukemia

, 12(3): 420 - 428

Bengt Simonsson, Henrik Hjorth-Hansen, Ole Weis Bjerrum and Kimmo Porkka


DOI: 10.2174/138945011794815301




Interferon Treatment in Patients with Hypereosinophilia

, 12(3): 429 - 432

Ole Weis Bjerrum


DOI: 10.2174/138945011794815211




Interferon-α Treatment in Systemic Mastocytosis

, 12(3): 433 - 436

Ole Weis Bjerrum


DOI: 10.2174/138945011794815293




Interferon-Alpha in the Treatment of Multiple Myeloma

, 12(3): 437 - 446

Teh Liane Khoo, Annette Juul Vangsted, Douglas Joshua and John Gibson


DOI: 10.2174/138945011794815329




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science